Search fresh public links, source activity, and ready-to-use post angles for Dmt Trials.
Fresh curated links around DMT trials are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Definium Therapeutics has announced strong results in a phase 3 trial of its single-dosed lysergide (LSD) drug DT120 in treating adults with major depressive disorder (MDD), meetin...
This morning, Definium Therapeutics announced positive topline results from its Phase 3 study of LSD (DT120) for major depressive disorder (MDD). It’s the first Phase 3 data for LS...
On Monday, Definium Therapeutics announced topline data from a Phase 3 trial of its LSD candidate (DT120) for major depressive disorder (MDD). Reaction to the topline has been broa...
Eight-hour sessions, two therapists, and MDMA as "a third therapist in the room." Inside Israel's race to reach the 60% of veterans standard therapy fails.
New research outlines a rigorous plan to map the mathematical architecture of human experience using the compound N,N-dimethyltryptamine (DMT).
From its headquarters in the heart of New York City, Definium Therapeutics has dropped topline phase 3 data for its psychedelic answer to depression that is almost certain to keep...
People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression symptoms compared to a placebo, the company announced Monday.
This morning, Compass Pathways shared 26-week data from its second Phase 3 study of COMP360 psilocybin for treatment-resistant depression (TRD). The data are from Part B of COMP006...
The Department of Veterans Affairs is launching a trial review on the safety and efficacy of MDMA assisted therapy for PTSD.
MONDAY, May 18, 2026 — Just a single dose of psilocybin can provide rapid relief from depression, a new small-scale clinical trial has shown. Within a week, people treated with one...
Last summer, Germany’s medicines regulator quietly green-lit a psilocybin compassionate use program, the first such pathway in the European Union (see Germany Establishes EU’s Firs...
Natural hallucinogens—psychoactive compounds such as psilocybin, mescaline, and N,N-dimethyltryptamine (DMT)—have long captured human fascination due to their profound effects on p...
When we think about psychedelic drugs, we think about rockstars taking trips to far-flung lands - but North East NHS medics are now part of life-changing clinical trials.
A new partnership between Americans for Ibogaine and Disabled American Veterans is fueling efforts to legalize ibogaine as a PTSD treatment, following a presidential executive orde...
A radical new treatment may be emerging.ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
In a pioneering effort at the University of Southern California, researchers from the Keck School of Medicine, the Brain and Creativity Institute (BCI), and the Norris Comprehensiv...
The agreement could help accelerate research into the use of MDMA, magic mushrooms and other psychedelics to address PTSD and other mental conditions.
The cash will support mid-stage trials of a prospect the company claims to have “best-in-disease” potential treating major depressive disorder.
Natural hallucinogens, such as psilocybin, mescaline, N,N-dimethyltryptamine (DMT) and related compounds, have generally received attention for their effects on human perception, e...
If I had been supported to integrate my altered-state experiences 36 years ago, how much suffering could have been alleviated? The post Where Psychedelics Meet Madness: Intersectio...
A new study demonstrates that a single dose of psilocybin-containing mushrooms temporarily restored spontaneous speech, motor independence, and urinary continence in an 80-year-old...
In June 2023, FDA issued the first draft guidance on clinical investigations involving psychedelics. The 11-page document offered pointers on everything from nonclinical research a...
Texas patients are traveling across the border to get their hands on a strong, unregulated psychedelic drug that they say is bringing renewed hope for mental health treatment.
It’s been an incredibly busy few weeks since our last Bulletin, with Psychedelic Alpha on the road in the U.S. (for APA’s annual meeting and a visit to Stanford and the valley), Th...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.